10-Q: Air Industries Group Reports Q2 Loss, Going Concern Warning

Air Industries Group reported a net loss for Q2 2025, a significant decline in sales, and a debt covenant default, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net sales for the three months ended June 30, 2025, decreased by 6.7% to $12,659,000, compared to $13,572,000 in the prior year.
• The company reported a net loss of $422,000 for the three months ended June 30, 2025, a significant decline from a net income of $298,000 in the same period last year.
• For the six months ended June 30, 2025, net sales decreased by 10.2% to $24,802,000, and the net loss widened to $1,410,000 from $408,000 in the prior year.
• Gross profit percentage declined to 16.0% for the three-month period and 16.4% for the six-month period, down from 19.5% and 16.5% respectively.
• The company defaulted on its Fixed Charge Coverage Ratio (FCCR) covenant, achieving 0.76x against a required 1.05x as of June 30, 2025.
• The Current Credit Facility expires on December 30, 2025, leading to the classification of the entire Term Loan as current debt.
• Management has begun negotiations with its lender and related party noteholders to extend debt maturity dates.
• The company's funded backlog as of June 30, 2025, was $128.5 million, with total unfilled contract values amounting to $272.9 million.
• Received gross proceeds of $1,243,000 from its At The Market (ATM) offering during the first half of 2025, and an additional $3,623,000 in July 2025.
• Employment was reduced in July 2025, expected to cut expenses by an estimated $1.0 million annually.
• A material weakness in internal controls over financial reporting related to IT systems remains unremediated.

Sentiment

Score: 3

Explanation: The company faces significant financial challenges, including declining sales, increased losses, and a critical debt covenant default leading to a going concern warning. While there's a strong backlog and recent capital raises, the immediate financial performance is poor, and the debt situation creates high uncertainty. The positive outlook for 2026 is distant and contingent on successful debt renegotiations.

Positives

• Cash flow from operating activities significantly increased to $1,870,000 for the six months ended June 30, 2025, up from $334,000 in the prior year.
• The company holds a strong funded backlog of $128.5 million and total unfilled contract values of $272.9 million, providing a foundation for future sales.
• Successful capital raises through the At The Market (ATM) offering generated $1,243,000 in H1 2025 and an additional $3,623,000 in July 2025.
• Cost reduction measures, including an estimated $1.0 million annual savings from employment reduction, were implemented in July 2025.
• Reduced related party debt by $1,291,000 during the six months ended June 30, 2025.
• The average interest rate on the Current Credit Facility decreased to 6.85% in 2025 from 7.85% in 2024.

Negatives

• Net sales decreased by 6.7% for the three months and 10.2% for the six months ended June 30, 2025, compared to the prior year periods.
• Gross profit declined significantly, and the gross profit percentage decreased from 19.5% to 16.0% for the three-month period.
• The company shifted from a net income of $298,000 in Q2 2024 to a net loss of $422,000 in Q2 2025.
• The net loss for the six months ended June 30, 2025, increased substantially to $1,410,000 from $408,000 in the prior year.
• The company defaulted on its Fixed Charge Coverage Ratio (FCCR) covenant, achieving 0.76x against a required 1.05x.
• The Current Credit Facility expires on December 30, 2025, classifying the entire Term Loan as current debt and raising substantial doubt about the company's ability to continue as a going concern.
• Operating expenses increased by 18.31% for the six-month period ended June 30, 2025, primarily due to stock compensation and IT system improvements.
• Cash balance decreased by 32.67% from December 31, 2024, to June 30, 2025.
• Working capital decreased by 17.07% from December 31, 2024, to June 30, 2025.
• Underutilization of personnel contributed to the decrease in gross margin.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to the Fixed Charge Coverage Ratio (FCCR) default and the impending expiration of the Current Credit Facility.
• The lender (Webster Bank) could exercise its rights under the Current Credit Facility, including increasing interest rates, refusing new revolving loans, or retaining funds from the collection account, due to the covenant default.
• The Current Credit Facility expires on December 30, 2025, and related party notes mature on July 1, 2026, requiring successful renegotiation or refinancing to avoid liquidity issues.
• Future capital raises or debt extensions may lead to significant shareholder dilution, increased interest expense, or more restrictive business or financial covenants.
• The ability to obtain additional funds is dependent on the state of financial markets, which can be adversely impacted by global events such as public health crises, conflicts, banking crises, and inflation.
• Reliance on sole-source suppliers for raw materials and parts creates vulnerability to supply chain disruptions, increased prices, or supplier failure.
• A key commercial aviation component sourced from China exposes the company to increased prices, with the company absorbing the first 5% of any cost increases.
• A large percentage of revenue is concentrated among a few prime aerospace and defense contractors (RTX, Lockheed Martin, Northrop), posing a risk if relationships deteriorate or major programs are cut.
• The company faces an ongoing shortage of skilled workers in the industry.
• A material weakness in internal controls over financial reporting related to IT systems remains unremediated, potentially affecting the reliability of financial reporting.
• An ongoing legal proceeding with Contract Pharmacal Corp. seeks damages in excess of $700,000, which could adversely impact financial results.
• Changes in the U.S. defense budget could materially impact demand for the company's military aviation products.
• Deterioration of general economic conditions could reduce demand for commercial air travel, impacting sales of commercial aviation products.

Future Outlook

Sales are not anticipated to increase until early 2026 due to long lead times for raw materials and complex manufacturing processes. Sales and profitability are expected to begin improving in early 2026 and continue to improve throughout the year. The company anticipates increases in funded orders in 2025 from both existing and new customers. Investments in capital equipment during fiscal 2025 will be limited to those necessary for competitiveness or to fulfill funded orders, with an additional $400,000 expected for tooling. The company believes it has sufficient liquidity for the next twelve months, contingent on successfully extending debt maturity dates.

Management Comments

• "Managements plans are to increase revenues and reduce costs and measures were taken to reduce costs early in the third quarter of 2025."
• "While the Companys backlog has grown as a result of recent contract awards, due to the long-lead times to acquire raw materials and the time needed to manufacture complex assemblies, the Company anticipates sales will not begin to increase until early next year."
• "Management has begun negotiations with both the lender of its Current Credit Facility and holders of its related party notes in an effort to extend the maturity dates of such debt."
• "We expect that sales and profitability will begin to improve in early 2026 and continue to improve during the balance of the year."
• "Although navigating the current business landscape remains challenging and it is difficult to predict period-to-period financial performance, based on the amounts recently raised pursuant to our ATM, our current revenue visibility and the strength of our backlog, we believe we have sufficient liquidity to meet our financial obligations for the next twelve months from the date of issuance of our condensed consolidated financial statements included in this Quarterly Report."
• "While we are focused on our business, we will explore our options to raise additional capital or borrow additional funds on terms which we believe are favorable."

Industry Context

The company operates as a leading manufacturer of precision components and assemblies for major aerospace and defense contractors, with products used in both U.S. military aviation (e.g., F-18, F-35, Black Hawk) and commercial aviation (e.g., Geared Turbo-Fan Engines). Demand for military products is primarily influenced by the U.S. defense budget, while commercial demand is tied to general economic conditions and air travel. The industry is characterized by high competition, requiring continuous investment in process improvements and capital equipment. The company often serves as a sole or single supplier for critical parts and faces an ongoing shortage of skilled workers.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or industry benchmarks to assess the results against global standards. The company notes that winning new contracts requires delivering superior quality products more quickly and with lower pricing than competitors, indicating a highly competitive market.

Corporate Governance

Legal Proceedings

• An ongoing legal action commenced on October 2, 2018, by Contract Pharmacal Corp. relating to a sublease, with Contract Pharmacal seeking damages in excess of $700,000. The company disputes the validity of these claims and intends to continue its defense.

Related Party Transactions

• Subordinated Notes Related Party totaling $4,871,000 were outstanding as of June 30, 2025, held by Michael Taglich and Robert Taglich (directors), and Taglich Brothers, Inc. (co-founded by the directors).
• During the six months ended June 30, 2025, the company paid $1,291,000 in principal payments on related party notes, including $1,050,000 to Michael Taglich and $241,000 to Taglich Brothers, Inc.
• Taglich Brothers, Inc. has acted as a placement agent for various debt and equity financing transactions, receiving cash and equity compensation for their services.
• Common stock was issued to directors in payment of fees, totaling $39,000 for the three months and $78,000 for the six months ended June 30, 2025.

Stakeholder Impact

• Shareholders face potential significant dilution from future equity raises and a risk of decreased share price due to poor financial performance and the going concern warning.
• Lenders, particularly Webster Bank, have increased leverage due to the company's default on its FCCR covenant, granting them rights to impose stricter terms or cease lending.
• Employees experienced employment reductions in July 2025, aimed at cutting annual expenses by an estimated $1.0 million.
• Customers may experience potential impacts on delivery schedules due to long lead times for raw materials and manufacturing, despite a strong backlog.
• Suppliers, especially sole-source providers, are critical to the company's operations, and any disruption could severely harm the business.

Next Steps

• Management plans to increase revenues and reduce costs, with measures already taken to reduce costs early in Q3 2025.
• Negotiations are underway with Webster Bank and related party noteholders to extend the maturity dates of outstanding debt.
• The company will continue testing controls and procedures designed to remediate the material weakness in its IT systems.
• Approximately an additional $400,000 is expected to be invested during the remainder of 2025, principally for tooling.
• The company will explore options to raise additional capital or borrow additional funds on terms it believes are favorable.
• Sales and profitability are expected to begin improving in early 2026 and continue to improve throughout the year.
• Increases in funded orders are anticipated in 2025 from existing and new customers.

Key Dates

Recommendation

The company's financial performance is deteriorating significantly, marked by declining sales, widening losses, and a critical default on its debt covenants. The explicit 'going concern' warning from management, coupled with the impending maturity of its primary credit facility, indicates severe financial distress and high operational risk. While a substantial backlog exists and recent capital has been raised, the immediate outlook is negative, with sales improvement not expected until early 2026. The need for debt renegotiation, potential for significant shareholder dilution from future capital raises, and unremediated internal control weaknesses further compound the risks. A seasoned investor would likely view this as a highly speculative investment with substantial downside risk and would seek to exit or avoid the stock until there is clear evidence of financial stabilization and successful resolution of the debt and going concern issues.

Keywords

Aerospace, Defense, Manufacturing, Precision Components, SEC Filing, 10-Q, Financial Results, Going Concern, Debt Default, Capital Raise, Supply Chain, Military Aviation, Commercial Aviation, Long-Term Agreements, Backlog